The HemOnc Pulse
Discussing the Role of MRD in CLL With Talal Hilal, MD
May 16, 2024
Dr. Hilal, of the Mayo Clinic, joins Chadi Nabhan, MD, MBA, FACP, on The HemOnc Pulse to discuss measurable residual disease (MRD) and the debates surrounding its use for response assessment in patients with chronic lymphocytic leukemia (CLL).
Blood Cancers Today and the Society of Hematologic Oncology bring you The HemOnc Pulse, a podcast hosted by Chadi Nabhan, MD, MBA, FACP, covering all topics in the world of hematologic oncology.
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast